Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Friedman

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
PDA Journal of Pharmaceutical Science and Technology|February 2, 2012
FDA post-approval expectations for adventitious virus contamination preventionRichard L Friedman
PDA Journal of Pharmaceutical Science and Technology|June 24, 2005
Aseptic processing contamination case studies and the pharmaceutical quality systemRichard L Friedman
FEMS Microbiology Letters|January 26, 2005
Bacterial luciferase is naturally destabilized in Mycobacterium tuberculosis and can be used to monitor changes in gene expressionEsteban A Roberts, Amanda Clark, Richard L Friedman
Archives of Surgery (Chicago, Ill. : 1960)|December 23, 2009
A unique case of recurrent metachronous volvulus of the gastrointestinal tractDimitrios V Avgerinos, Omar H Llaguna, Richard L Friedman
Journal of Bacteriology|August 5, 2004
Molecular characterization of the eis promoter of Mycobacterium tuberculosisEsteban A Roberts, Amanda Clark, Sarah McBeth, et al.
FEMS Microbiology Letters|May 9, 2008
Bordetella bronchiseptica responses to physiological reactive nitrogen and oxygen stressesAnders Omsland, Katrina M Miranda, Richard L Friedman, et al.
PDA Journal of Pharmaceutical Science and Technology|April 12, 2012
Author responseDiane Raccasi, Dennis E Guilfoyle, Richard L Friedman, et al.
PDA Journal of Pharmaceutical Science and Technology|February 2, 2012
Burkholderia cepacia: This Decision Is OverdueLynn Torbeck, Diane Raccasi, Dennis E Guilfoyle, et al.
JAMA Network Open|August 25, 2020
Quality Testing of Difficult-to-Make Prescription Pharmaceutical Products Marketed in the USAdam C Fisher, Alex Viehmann, Melika Ashtiani, et al.
PDA Journal of Pharmaceutical Science and Technology|April 10, 2013
Microbial Risk in Pharmaceutical Manufacturing and ICH Q9Dennis E Guilfoyle, Richard L Friedman, Patricia F Hughes, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
PDA Journal of Pharmaceutical Science and Technology|February 2, 2012
FDA post-approval expectations for adventitious virus contamination preventionRichard L Friedman
PDA Journal of Pharmaceutical Science and Technology|June 24, 2005
Aseptic processing contamination case studies and the pharmaceutical quality systemRichard L Friedman
FEMS Microbiology Letters|January 26, 2005
Bacterial luciferase is naturally destabilized in Mycobacterium tuberculosis and can be used to monitor changes in gene expressionEsteban A Roberts, Amanda Clark, Richard L Friedman
Archives of Surgery (Chicago, Ill. : 1960)|December 23, 2009
A unique case of recurrent metachronous volvulus of the gastrointestinal tractDimitrios V Avgerinos, Omar H Llaguna, Richard L Friedman
Journal of Bacteriology|August 5, 2004
Molecular characterization of the eis promoter of Mycobacterium tuberculosisEsteban A Roberts, Amanda Clark, Sarah McBeth, et al.
FEMS Microbiology Letters|May 9, 2008
Bordetella bronchiseptica responses to physiological reactive nitrogen and oxygen stressesAnders Omsland, Katrina M Miranda, Richard L Friedman, et al.
PDA Journal of Pharmaceutical Science and Technology|April 12, 2012
Author responseDiane Raccasi, Dennis E Guilfoyle, Richard L Friedman, et al.
PDA Journal of Pharmaceutical Science and Technology|February 2, 2012
Burkholderia cepacia: This Decision Is OverdueLynn Torbeck, Diane Raccasi, Dennis E Guilfoyle, et al.
JAMA Network Open|August 25, 2020
Quality Testing of Difficult-to-Make Prescription Pharmaceutical Products Marketed in the USAdam C Fisher, Alex Viehmann, Melika Ashtiani, et al.
PDA Journal of Pharmaceutical Science and Technology|April 10, 2013
Microbial Risk in Pharmaceutical Manufacturing and ICH Q9Dennis E Guilfoyle, Richard L Friedman, Patricia F Hughes, et al.
Pageof 2